The Framingham score is a marker of early disability progression in multiple sclerosis

Felipe C D Barros1, Felipe T L Menezes1, Natasha P A Bessa1

  • 1Universidade Federal de São Paulo. São Paulo, Brazil.

Abstract

Insights

Cardiovascular risk, measured by the Framingham Score, is linked to increased disability in multiple sclerosis (MS) patients. This association is particularly strong in early disease stages, highlighting the importance of managing cardiovascular health in MS prognosis.

Area of Science:

  • Neurology
  • Cardiology
  • Public Health

Background:

  • Prognosis of multiple sclerosis (MS) can be influenced by cardiovascular risk factors.
  • The Framingham Score systematically assesses cardiovascular risk and its impact on MS outcomes.

Purpose of the Study:

  • To determine if the Framingham Score predicts increased disability in MS, specifically reaching an Expanded Disability Status Scale (EDSS) of 6.
  • To investigate this association in a multiethnic population within a middle-income country.

Main Methods:

  • Retrospective analysis of 284 MS patients' medical records from 1994-2019.
  • Logistic regression and decision tree algorithms were used to evaluate the relationship between Framingham Score and EDSS.
  • Adjustments were made for confounding risk factors like age.

Main Results:

  • Patients reaching EDSS 6+ had a higher mean Framingham Score (9.9) than those who did not (5.8).
  • A significant positive correlation (rₛ = 0.414) was found between Framingham Score and last-visit EDSS.
  • In early MS (EDSS 0-2.5), higher Framingham Scores significantly predicted greater disability, with 25.3% reaching EDSS ≥ 6 versus 3.9%.

Conclusions:

  • Cardiovascular risk, assessed by Framingham Score, is associated with disability progression in a middle-income MS cohort.
  • The association is stronger in patients with early-stage MS (EDSS 0-2.5).
  • Managing cardiovascular risk factors early in MS may be crucial for mitigating long-term disability.